Novo Asks SCOTUS to Review Foreign Manufacturer Liability Wrinkles

Foreign manufacturers of FDA-approved drugs should not be held liable for personal injury in U.S. courts in cases where a U.S. subsidiary is the sponsor of a drug found to be injurious, Denmark’s Novo Nordisk claims in a petition for writ of certiorari filed with the Supreme Court.
Washington Drug Letter